Literature DB >> 19366724

The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer.

Ryo Maeda1, Noritaka Isowa, Hideyuki Onuma, Hiroshi Miura, Tomoya Harada, Hirokazu Touge, Hirokazu Tokuyasu, Yuji Kawasaki.   

Abstract

In patients with clinical stage IA non-small cell lung cancer (NSCLC), we investigated whether the maximum standardized uptake value (SUVmax) of 18F-fluorodeoxyglucose (FDG) by the tumor correlated with lymph node metastasis, intratumoral lymphatic and vascular invasion of tumor cells, and pleural invasion. From April 2005 to November 2008, 58 patients underwent a lobectomy with systematic hilar and mediastinal lymph node dissection for clinical stage IA NSCLC. All patients had integrated FDG-positron emission tomography (PET)/computed tomography (CT) performed in our center as part of the preoperative workup within one month of resection. The relationships between the SUVmax and pathologic results of lymph node metastasis, intratumoral lymphatic and vascular invasion of tumor cells, and pleural invasion were examined. Compared with tumors with an SUVmax < or = 2.0, tumors with an SUVmax>2.0 had more frequent lymph node metastasis, intratumoral lymphatic and vascular invasion of tumor cells and pleural invasion (all P<0.05). Our results suggest that in patients with clinical stage IA NSCLC, SUVmax is an important predictor of tumor invasiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19366724     DOI: 10.1510/icvts.2008.201251

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  8 in total

1.  Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.

Authors:  Jingbo Wang; Kathy Welch; Luhua Wang; Feng-Ming Spring Kong
Journal:  Clin Lung Cancer       Date:  2011-11-03       Impact factor: 4.785

2.  FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value.

Authors:  Marina Suárez-Piñera; José Belda-Sanchis; Alvaro Taus; Albert Sánchez-Font; Antoni Mestre-Fusco; Marcel Jiménez; Lara Pijuan
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

3.  Dissection of the left paratracheal area is frequently missed during left side non-small cell lung cancer surgery.

Authors:  Gonzalo Varela; Marcelo F Jiménez
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

4.  Can Initial (18)F-FDG PET-CT Imaging Give Information on Metastasis in Patients with Primary Renal Cell Carcinoma?

Authors:  Haejun Lee; Kyung Hoon Hwang; Seog Gyun Kim; Geon Koh; Ji Hyun Kim
Journal:  Nucl Med Mol Imaging       Date:  2013-11-28

5.  Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma.

Authors:  X-Y Duan; W Wang; M Li; Y Li; Y-M Guo
Journal:  Braz J Med Biol Res       Date:  2015-02-03       Impact factor: 2.590

6.  Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.

Authors:  Huang Miao; Li Shaolei; Li Nan; Lai Yumei; Zhang Shanyuan; Lu Fangliang; Yang Yue
Journal:  Thorac Cancer       Date:  2019-05-24       Impact factor: 3.500

7.  Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer.

Authors:  Meng Li; Ning Wu; Rong Zheng; Ying Liang; Ying Liu; Wenjie Zhang; Ni Li; Ping Zhao
Journal:  Cancer Imaging       Date:  2013-02-07       Impact factor: 3.909

8.  Preoperative predictors of lymph node metastasis in clinical T1 adenocarcinoma.

Authors:  Kenta Nakahashi; Nobuo Tsunooka; Kyo Hirayama; Masahiro Matsuno; Mareyuki Endo; Junichi Akahira; Masataka Taguri
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.